founder & CEO of Kymera Therapeutics, based in Massachusetts
Kymera Therapeutics is a Cambridge, Massachusetts-based biotechnology company specialized in the field of targeted protein degradation.
Atlas Venture creates and invests in biotech startup companies in the U.S. with seed and early stage venture investments.